cas no.13463-67-7 factory
Harnessing Sustainable Titanium Dioxide Production in Eco-Friendly Factories
In addition to our high-quality products, we also offer competitive pricing and fast shipping
In conclusion, barium zinc sulfate stands as a testament to the intricate relationship between modern industry and specialized chemicals. As its applications continue to expand, partnering with a dependable supplier will remain at the core of maintaining a competitive edge in the ever-evolving landscape of industrial manufacturing.
In conclusion, China's Tio2 pigment industry plays a pivotal role in the global market, not just in terms of volume but also in setting trends and influencing pricing strategies. As the world continues to grapple with economic and environmental challenges, China's ability to balance growth with sustainability will be a key factor in determining the future trajectory of the Tio2 pigment industry.
2.3(ZnS), 1.64(BaSO4)
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”